|
|
|
January 12, 2004
Features
Cover Story: Dramatic advances may help biotechs develop drugs that slow aging.
By Karen Hopkin
The Life Science Identifier could help scientists find and share research data.
By Salvatore Salamone
| Special Issue |
|
| · |
Follow this program to avoid violations.
By Barbara Depompa |
| · |
Validating computer systems is unavoidable. The key is to minimize time and cost.
By Bob Violino |
| · |
Create a corporate culture of compliance.
By Steve Lefar |
| · |
Process integration isn't just good insurance.
By Lisa Griffith
|
Horizons
Conversation: Greg Lucier
Invitrogen's president discusses determinism in drug development.
Company to Watch
Under the guidance of Peter Schultz, Ambrx tinkers with the building blocks of life.
Guest Commentary
Wood Mackenzie's Simon Smyth looks at product portfolios and pipelines to forecast pharma's future.
Departments
News & Analysis
New Drug Costs Sky-High: $1.7B
Fujitsu BioServer Uses Economy Chips
Software Speeds Chemistry Calculations
Nextrials Integrates Lab and Clinic
Hurdles in the Path of Personalized Medicine
Race Is On in Molecular Diagnostics
Columns
Presidential Material | Morris R. Levitt
What's new for the year ahead.
First Base | Kevin Davies
Speedier delivery, added content, daily news, and your Best Practices.
Inside the Box | Bill Van Etten
The one question to ask about computer benchmarks.
Nothing Ventured... | Michael A. Greeley
Better image analysis, better business models.
Fully Equipped | By Julia Boguslavsky
Instrumentation outlook for systems biology.
The Russell Transcript | By John Russell
Facing tough competition, Sun Microsystems needs a few blowtorches.
|
|
|
|